Stock listing
NASDAQ:RACB Research Alliance Corp II Stock
Follow Research Alliance Corp II into a list and get an email when it puts out news.
Last close · NASDAQ:RACB
$10.11 USD
Close on Dec 15, 2022 · No longer trades
- Lowest – highest close
- $9.66 – $11.29 USDSince Mar 18, 2021 · lowest Jan 24, 2022 · highest Apr 14, 2021
Delisted NASDAQ:RACB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RACB
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Matthew Hammond Other companies: Research Alliance Corporation IV (Chief Executive Officer, Director · Since at least Jul 10, 2026); Research Alliance Corporation III (Chief Executive Officer, Director · Since at least May 19, 2026); POINT Biopharma Global Inc (Chief Financial Officer, Director · Jul 7, 2020 – Jul 7, 2020 · Past) | Chief Investment Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past |
| Thomas Leggett Other companies: Stoke Therapeutics, Inc. (Chief Financial Officer · Since at least May 7, 2024); Black Diamond Therapeutics, Inc. (Chief Financial Officer · Jan 29, 2020 – Feb 17, 2021 · Past); Axcella Health Inc (SVP Finance, CFO · May 8, 2019 – May 8, 2019 · Past) | Director · Mar 17, 2021 – Mar 17, 2021 · Past |
| Theresa Cameron Other companies: Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Jul 22, 2021 · Past) | Chief Financial Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past |
Log in to ask 6ix AI your own questions about Research Alliance Corp II.